These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 28901856)
21. [What's new in ocular surface disease?]. Messmer EM; Benitez-Del-Castillo JM; Lambiase A; Doan S Ophthalmologe; 2005 Mar; 102(3):293-300. PubMed ID: 15616816 [TBL] [Abstract][Full Text] [Related]
22. Allergic inflammation of the anterior surface of the eye. Bielory L Allergy Asthma Proc; 2020 Nov; 41(6):449-453. PubMed ID: 33109311 [No Abstract] [Full Text] [Related]
23. Emerging therapies targeting eosinophil-mediated inflammation in chronic allergic conjunctivitis. Fernandez A; Asbell P; Roy N Ocul Surf; 2022 Oct; 26():191-196. PubMed ID: 35970432 [TBL] [Abstract][Full Text] [Related]
24. [Use of cyclosporine 0.05% in various ocular surface disorders]. Maĭchuk DIu; Vasil'eva OA; Shokirova MM Vestn Oftalmol; 2014; 130(2):68-71. PubMed ID: 24864503 [TBL] [Abstract][Full Text] [Related]
25. New ocular therapeutics: a view from the patenting perspective. Mucke HA IDrugs; 2007 Jan; 10(1):37-41. PubMed ID: 17187313 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic applications of antiflammin peptides in experimental ocular inflammation. Chan CC; Tuaillon N; Li Q; Shen DF Ann N Y Acad Sci; 2000; 923():141-6. PubMed ID: 11193752 [TBL] [Abstract][Full Text] [Related]
27. Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases. Kovalchin J; King B; Masci A; Hopkins E; Fry J; Hou J; Li C; Tenneson K; Weber S; Wolfe G; Collins K; Furfine ES Eye Contact Lens; 2018 May; 44(3):170-181. PubMed ID: 28727604 [TBL] [Abstract][Full Text] [Related]
28. Ectoine in the Treatment of Irritations and Inflammations of the Eye Surface. Bilstein A; Heinrich A; Rybachuk A; Mösges R Biomed Res Int; 2021; 2021():8885032. PubMed ID: 33628826 [TBL] [Abstract][Full Text] [Related]
36. Recent overview of ocular patents. Gaudana RJ; Gokulgandhi MR; Boddu SH; Mitra AK Recent Pat Drug Deliv Formul; 2012 Aug; 6(2):95-106. PubMed ID: 22493994 [TBL] [Abstract][Full Text] [Related]
37. [Emphasizing the prevention and anti-inflammation research of dry eye disease]. Zhang MC; Bian F Zhonghua Yan Ke Za Zhi; 2013 Jan; 49(1):6-7. PubMed ID: 23601457 [TBL] [Abstract][Full Text] [Related]
38. Clinical review: topical ophthalmic use of cyclosporin A. Utine CA; Stern M; Akpek EK Ocul Immunol Inflamm; 2010 Oct; 18(5):352-61. PubMed ID: 20735287 [TBL] [Abstract][Full Text] [Related]
40. Novel drug delivery systems for the management of dry eye. Nagai N; Otake H Adv Drug Deliv Rev; 2022 Dec; 191():114582. PubMed ID: 36283491 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]